2024-12-23 08:57:17
Author: RhoVac / 2023-07-23 21:54 / Source: RhoVac

RhoVac Marketed in International Press


STOCKHOLM,July 1,2020 --

RhoVac AB ("RhoVac") is marketed in the latest edition of the international trade press outlet,MedNous,through a written commentary by CEO Anders Månsson.

In order to further attract the attention of potential partners and increase their interest in RhoVac's achievements as well as plans for the future,RhoVac's CEO Anders Månsson has written a commentary on the company in the latest edition of MedNous that was published last week.

CEO Anders Månsson comments: "It is important that we market RhoVac more broadly than what can be accomplished in direct bi-lateral meetings,whether physical or digital. By reaching out also via international press,informing on our achievements and our plans,we reach also broader audience and that is important from a business perspective."

Link to commentary: https://www.rhovac.com/investors/presentations/

For further information,please contact:

Anders Månsson – CEO,RhoVac AB


Phone number: +46 73-751-72-78


E-mail: info@rhovac.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/rhovac/r/rhovac-marketed-in-international-press,c3145633

The following files are available for download:

https://mb.cision.com/Main/13747/3145633/1272594.pdf

Release

Tags: Biotechnology Health Care/Hospital Medical/Pharmaceuticals Pharmaceuticals

Previous:

Next:

Leave a comment

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release